grk-2 cDNA expression in command interneurons (Pnmr-1, transgene yakSi32) is sufficient to rescue the slow locomotion of grk-2(gk268) mutant animals. (****, P0.05. One way ANOVA followed by a Bonferroni test. Error bars = SEM; n = 20). (PDF)</p
GRK-2 positively controls (A) crawling and swimming by acting in premotor interneurons in a manner t...
grantor: University of TorontoAdaptor proteins are a subset of signaling proteins that lac...
<p>(A–C) Representative L1 animals labeled with an anti-myosin heavy chain-A (MHC-A) antibody. Scale...
<p>(A) <i>grk-2</i> is expressed in command interneurons. Representative images of a Z-stack project...
(A) The npr-1(ky13) mutation suppresses the exploration defect of grk-2(gk268) mutants as assayed on...
(A) Expression of grk-2 cDNA under a pan-neuronal promoter rescues the exploration defect of grk-2 m...
(A), (B) The egl-4(n479) mutation partially suppresses the exploration defect of grk-2(gk268) mutant...
<p>(A,B) A <i>grk-2</i> mutation partially suppresses activated Rho. Animals expressing activated RH...
(A) Schematic representation of the assay used to measure dispersal (see Methods). (B) grk-2(gk268) ...
(A) The aptf-1(gk794) mutation partially suppresses the exploration defect of grk-2(gk268) mutant. S...
(A) grk-2(gk268) mutant animals have an exploration defect and flp-1(ok2811) significantly suppresse...
(A) grk-2(gk268) and pdfr-1(ok3425) mutants have exploration defects. The double mutant grk-2(gk268)...
(A) The flp-11(tm2706) mutation does not affect the exploration defect of grk-2(gk268) mutant animal...
(A) (Up) Schematic diagram of the coelomocyte uptake assay used to quantify FLP-1 secretion from AVK...
(A) ocr-2(ak47), ocr-2(ok1717) (strains BJH2763 and BJH2762, respectively) and kin-29(oy38) mutants ...
GRK-2 positively controls (A) crawling and swimming by acting in premotor interneurons in a manner t...
grantor: University of TorontoAdaptor proteins are a subset of signaling proteins that lac...
<p>(A–C) Representative L1 animals labeled with an anti-myosin heavy chain-A (MHC-A) antibody. Scale...
<p>(A) <i>grk-2</i> is expressed in command interneurons. Representative images of a Z-stack project...
(A) The npr-1(ky13) mutation suppresses the exploration defect of grk-2(gk268) mutants as assayed on...
(A) Expression of grk-2 cDNA under a pan-neuronal promoter rescues the exploration defect of grk-2 m...
(A), (B) The egl-4(n479) mutation partially suppresses the exploration defect of grk-2(gk268) mutant...
<p>(A,B) A <i>grk-2</i> mutation partially suppresses activated Rho. Animals expressing activated RH...
(A) Schematic representation of the assay used to measure dispersal (see Methods). (B) grk-2(gk268) ...
(A) The aptf-1(gk794) mutation partially suppresses the exploration defect of grk-2(gk268) mutant. S...
(A) grk-2(gk268) mutant animals have an exploration defect and flp-1(ok2811) significantly suppresse...
(A) grk-2(gk268) and pdfr-1(ok3425) mutants have exploration defects. The double mutant grk-2(gk268)...
(A) The flp-11(tm2706) mutation does not affect the exploration defect of grk-2(gk268) mutant animal...
(A) (Up) Schematic diagram of the coelomocyte uptake assay used to quantify FLP-1 secretion from AVK...
(A) ocr-2(ak47), ocr-2(ok1717) (strains BJH2763 and BJH2762, respectively) and kin-29(oy38) mutants ...
GRK-2 positively controls (A) crawling and swimming by acting in premotor interneurons in a manner t...
grantor: University of TorontoAdaptor proteins are a subset of signaling proteins that lac...
<p>(A–C) Representative L1 animals labeled with an anti-myosin heavy chain-A (MHC-A) antibody. Scale...